| abstract |
The present invention relates to the identification, synthesis, optimization and identification of compounds that are inhibitors or activators of proteins that are naturally occurring endogenous proteins and variant forms of certain endogenous proteins and to the identification of said variants new method. Drug discovery and production methods are simplified through improved hit identification, lead optimization, biorecognition, and rapid exclusion of toxic compounds, thereby accelerating the identification and development of compounds as potentially therapeutically effective drugs. This implementation leads to a reduction in the overall cost of the drug discovery process due to a corresponding increase in efficiency. |